Chris karps,SwedenAlways pleasure to work with you Wendy! Good communication, service minded and top notch products .
Andy Marchant,United Kingdomvery happy and tell you every step of the way posted when arrived and when due for delivery the quality is excellent
shane bassette,United StatesThis company is one worth buying from I have purchased several times from them and will continue buying in the future , Excellent customer service Very helpful with my order I would give them 10 stars if I could Thanks again
Raw Peptides Powder AOD-9604 For Anti Obesity Drug CAS 221231-10-3
|Place of Origin||China|
|Minimum Order Quantity||1 box|
|Packaging Details||2mg per vial 10 vails/box, white box packaging and any method of packing applicable to the product.For safe delivery.|
|Delivery Time||1-3 working days to ship, about 3-12 working days for delivery|
|Payment Terms||, , T/T, Bank transfer and BTC or Another Reliable Payment Method|
|Supply Ability||5000 boxes per month|
|Grade Standard||Medicine Grade||Cas No.||221231-10-3|
|Shelf Life||2 Years||Assay||HPLC 99%|
|Color||White Powder||Storage||Cold Storage|
Injectable Peptides Fragment AOD9604 Powder For Fat Loss CAS: 221231-10-3
Molecular formula: C78H123N23O23S2
Molar Mass: 1815.08152
CAS number: 221231-10-3
PubChem: CID 71300630
Synonyms: hGH Fragment 177-191, AOD-9604, 221231-10-3
AOD9604 is a peptide fragment (H Fragment 177-191) of the C-terminus of Human G H to which a tyrosine is added at the N-terminal end. Studies have suggested that AOD9604 is more effective than its predecessor AOD9401 in its ability to stimulate lipolytic (fat burning) and anti-lipogenic activity. Like G H, AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (prevents the transformation of fatty food materials into body fat) both in laboratory testing and in animals and humans. Recent clinical research studies have shown that AOD9604 did show a reduction of body fat in the mid abdominal area in both obese, over-weight, and average built people.
The Development of AOD9604 from Human G H
Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a sML region near one end of the GH molecule. This region, which consists of amino acids 177-191, is less than 10% of the total size of the GH molecule and appears to have no effect on growth or insulin resistance. It works by mimicking the way natural G H regulates fat metabolism but without the adverse effects on blood sugar or growth that is seen with unmodified G H.
The Fat Loss Properties of AOD 9604
In laboratory tests on fat cells from rodents, pigs, dogs, and humans, the H fragment released fat specifically from obese fat cells but not from lean ones, reduced new fat accumulation in all fat cells, enhanced the burning of fat. In rodents (rats and mice), H fragment reduced body fat in obese animals but, enhanced fat burning without changing food consumption or inducing growth (as it does not increase IGF levels) or any other unwanted G H effect. Recent research has shown AOD9604 to be an extremely potent and effective fat burner. Metabolic is developing AOD-9604 for the potential treatment of obesity. Research studies have shown that AOD9604 actually acts on the reduction of excessive adipose tissues such as those in the abdominal area, increase in muscle mass, and enhances the lipid content of the body.
These segments of the synthetic peptide AOD9604 have been researched for their in vivo effects in laboratory mice musculus. Results have shown that AOD9604 have resulted to a short-period increase in blood glucose and a more sustained increase in plasma insulin, together with other fragments such as 172-191, 177-191 and 178-191. In addition, the researchers have suggested that functionality of the peptide depends not only in the informational sequence but should also have the correct physical configuration (Ng and Borstein 1978). Also, AOD9604, being a region of high accessibility to proteases and also rich in proline, have been demonstrated to affect the conformational change in the cytoplasmic domain of the band 3 of erythrocyte membrane protein by serving as the hinge for the pivoting of the two subdomains. This then suggest that such residue is significant in conformational changes be serving as sites for peripheral protein binding in some body cells (Low et al. 1984).
AOD9604 - What is it?
AOD9604 is a peptide (a chain of amino acids) which was developed and patented by a company called Metabolic Pharmaceuticals in Australia in the late 1990s. AOD stands for "Anti Obesity Drug". This peptide has an amino acid sequence that mimics the lipolytic region of human G H (the region of this hormone thought to be responsible for burning fat) and it has been promoted variously as a weight loss supplement, as an aid to muscle and cartilage repair, and a treatment for osteoarthritis by its manufacturers. It is also known as lipotropin and Tyr-H fragment, and is generally available these days as a transdermal cream or an injectable.
|HGH||2iu||CJC1295 With DAC||2mg|
|HGH||10iu||CJC1295 With DAC||5mg|
|HGH||15iu||CJC1295 without DAC||2mg|
|HGH PEN||10iu||CJC1295 without DAC||5mg|
|HGH Raw Powder||>99%||MGF||2mg|
|HCG Raw Powder||>99%||PEG MGF||2mg|
|HGH Fragment 176-191||2mg||Sermorelin||2mg|
|HGH Fragment 176-191||5mg||MT1||10mg|
|HGH Fragment 176-191||10mg||MT2||10mg|
Human Growth Hormone Somatropin HGH 191aa Injections Buy Powder 191 aa hgh HGH Growth Hormone 191aa